title: Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo.
abstract: The role of erythropoietin (Epo) in angiogenesis has not been completely clarified. Epo induces endothelial cell proliferation and migration and stimulates angiogenesis on rat aortic rings in vitro and in vivo in the chick embryo chorioallantoic membrane (CAM) assay. The aim of the present study was to evaluate the ultrastructural aspects of angiogenesis in the CAM vasculature after recombinant human Epo (rHuEpo) exposure. The results demonstrated that after rHuEpo stimulation, the generation of new blood vessels occurred more frequently following an intussusceptive microvascular growth (IMG) mechanism. We have performed our experiments between days 8 and 12 of incubation, that is, when in the normal condition the capillary network expands mainly by IMG, and because it is generally accepted that implants made from days 8 to 10 are strongly angiogenic. This response is peculiar of rHuEpo, because it is abolished when an Epo-blocking antibody was coadministered with Epo.
authors.affiliation: Department of Medical and Morphological Researches, Anatomy Section, University of Udine Medical School, Udine, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Crivellato
authors.forename: B
authors.initials: B
authors.lastname: Nico
authors.forename: A
authors.initials: A
authors.lastname: Vacca
authors.forename: V
authors.initials: V
authors.lastname: Djonov
authors.forename: M
authors.initials: M
authors.lastname: Presta
authors.forename: D
authors.initials: D
authors.lastname: Ribatti
mesh_terms: D000818:Animals; D002642:Chick Embryo; D004625:Embryo, Nonmammalian / Q000098:blood supply; D042783:Endothelial Cells / Q000737:chemistry / Q000648:ultrastructure; D004921:Erythropoietin / Q000494:pharmacology*; D006801:Humans; D007443:Intussusception / Q000139:chemically induced*; D008833:Microcirculation / Q000187:drug effects / Q000196:embryology / Q000648:ultrastructure; D008854:Microscopy, Electron; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D017467:Receptors, Erythropoietin / Q000032:analysis; D011994:Recombinant Proteins; D013997:Time Factors
chemical_list: D017467:Receptors, Erythropoietin; D011994:Recombinant Proteins; D004921:Erythropoietin